NextSeq 1000
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Health Agency Contracting Activity is pursuing a sole-source acquisition under FAR 12.102(a) for the NextSeq 1000 Sequencing System from ILLUMINA, INC, as it is the only source capable of meeting the mission-critical requirements of the Armed Forces Medical Examiner System DNA Operations at Dover Air Force Base, Delaware. The system must deliver an integrated DNA-to-analysis workflow capable of rapid sequencing of targeted panels, whole mitochondrial genomes, and SNP analysis in a single run, with performance benchmarks including at least 90% of bases at Q30 quality, 2x300 bp read lengths, up to 120 Gb per run, and run times between 8 and 42 hours. The procurement includes the instrument with 288 GB RAM and 3.8 TB SSD, onboard Linux CentOS software, initial XLEAP-SBS reagent kits, a three-year Silver Support Plan commencing after the initial one-year manufacturer warranty, and full installation with Installation and Operational Qualification per manufacturer standards. The system must also integrate with the AFMES Laboratory Information Management System for seamless .txt worklist import and data export, maintain backward compatibility with current forensic assays, and provide a documented upgrade path to the NextSeq 2000 platform. This acquisition is conducted under simplified acquisition procedures with no set-aside restrictions and falls under NAICS code 334516, which has a small business size standard of 1,000 employees. The contract requires total vendor accountability for shipping, handling, and insurance of the system to Dover AFB, with no specific packaging, preservation, or labeling standards defined beyond the requirement for RFID tracking of consumables. Technical capability statements, including detailed cost information, must be submitted by July 13, 2026, at 9:00 AM EST via email in PDF, Word, or Excel format to the designated point of contact. While the presolicitation notice identifies Illumina as the only technically acceptable provider, any responses received will be evaluated to determine whether competition is warranted, though the government retains full discretion in deciding whether to proceed without competition. No formal contract type, pricing, or clauses have been finalized, as this phase remains informational and preparatory, with award contingent on vendor submissions and government determination of sole-source justification.
General Info
Agency
NAICS
Place of Performance
Dover AFB, DE, USASet-Aside
Timeline
Response Deadline
Organization & Contact Information
Full Description
The Defense Health Agency Contracting Activity (DHACA) in Fort Detrick, MD intends to negotiate on a sole source basis (IAW RFO 12.102(a)) with ILLUMINA, INC 5200 Illumina Way, San Diego, CA 9212-4616 as the only responsible source that can provide the NextSeq 1000 Sequencing System. This is a Presolicitation notice in accordance with RFO 5.101.
The equipment provided by ILLUMINA INC is the only source that provides DHACA with the NextSeq 1000 Sequencing System and extended warranty used at the Armed Forces Medical Examiner System DNA Operations (AFMES-DNA OPS) to support their mission. Its fast, integrated DNA-to-analysis workflow allows for the rapid sequencing of targeted panels, whole mitochondrial genomes, and supports single nucleotide polymorphism (SNP) analysis in a single run. The extended warranty shall commence when 12-month Manufacturer Warranty expires.
This acquisition is being conducted under simplified acquisition procedures. There are no set-aside restrictions for this requirement. The intended procurement will be classified under North American Industry Classification System (NAICS) 334516 with a Small Business Size Standard of 1,000 employees. This presolicitation notice is not a request for competitive proposals and no solicitation document exists for this requirement. However, any parties interested in responding to this notice shall submit technical data, including cost, sufficient to determine capability in providing the same service. All capability statements received by closing of this notification of this synopsis will be considered by the Government. A determination by the Government not to compete based on responses to this notice is solely within the discretion of the Government. Information received will normally be considered solely for the purpose of determining whether to conduct a competitive procurement.
Based on the above information, the only technically acceptable subscription can be provided by ILLUMINA INC .
Submit email capability statements (using PDF, MS Word, Excel attachments) to Alicia Maldonado Torres at alicia.maldonadotorres.civ@health.mil. Statements are due no later than 09:00 AM EST on 13 July 2026